Angiosarcoma of breast
Citation, DOI & article data
Breast angiosarcomas are a rare vascular breast malignancy.
As primary tumors of the breast, they account for ~0.04% 2 of all breast cancers and tend to occur in younger women, in their 3rd to 4th decades.
Secondary angiosarcoma, related to prior therapy of breast cancer, has an estimated incidence of ~0.09-0.16% and occurs in older women (peak age 6th decade 2).
The classic presentation is a painless localized blue or purple color change of the breast skin, with singular or multifocal lesions which may resemble other benign vascular lesions such as angioma or telangiectasis 9,10.
Patients may also present with swelling, a sensation of fullness, or rapid breast growth 10.
The tumors are of endovascular origin. There are two main types:
- primary angiosarcoma of the breast
- secondary angiosarcoma of the breast
Specific location of the tumor varies according to whether it is a primary or secondary lesion:
- primary breast angiosarcoma are thought to arise within the breast parenchyma, with secondary involvement of the skin 11
- secondary breast angiosarcoma mainly involve the skin, with or without involvement of underlying breast parenchyma 11
- prior breast irradiation: radiation-induced breast angiosarcomas tend to occur after a significant latent period post-radiation (~5 years)
- Stewart-Treves syndrome
Lesions can sometimes be occult on mammography 7.
A heterogeneous mass is usually seen on MRI. Reported signal characteristics include 7:
- T1: usually low signal intensity
- T2: usually high signal intensity
- C+ (Gd): low-grade lesions show progressive enhancement whereas high-grade lesions show rapid enhancement and washout
Treatment and prognosis
Angiosarcoma of the breast is an extremely aggressive tumor and is associated with a poor prognosis.
The tumor may be mis-diagnosed on the basis of fine-needle biopsy; thus, core biopsy is mandatory for diagnosis 12.
Surgical excision with wide margin is the standard of care, typically a mastectomy. Axillary nodal dissection is usually not performed, as the malignancy features hematogenous spread.
Despite aggressive surgery, there is a high local and distant recurrence rate.
- 1. Lim RF, Goei R. Best cases from the AFIP: angiosarcoma of the breast. Radiographics. 2007;27 Suppl 1 : S125-30. doi:10.1148/rg.27si075016 - Pubmed citation
- 2. Glazebrook KN, Magut MJ, Reynolds C. Angiosarcoma of the breast. AJR Am J Roentgenol. 2008;190 (2): 533-8. doi:10.2214/AJR.07.2909 - Pubmed citation
- 3. Sanders LM, Groves AC, Schaefer S. Cutaneous angiosarcoma of the breast on MRI. AJR Am J Roentgenol. 2006;187 (2): W143-6. doi:10.2214/AJR.05.1940 - Pubmed citation
- 4. Tiwary SK, Singh MK, Prasad R et-al. Primary angiosarcoma of the breast. Surgery. 2007;141 (6): 821-2. doi:10.1016/j.surg.2006.06.013 - Pubmed citation
- 5. Marchant LK, Orel SG, Perez-jaffe LA et-al. Bilateral angiosarcoma of the breast on MR imaging. AJR Am J Roentgenol. 1997;169 (4): 1009-10. AJR Am J Roentgenol (citation) - Pubmed citation
- 6. Fant J, Grant M, May S et-al. Angiosarcoma of the breast: mammographic, clinical, and pathologic correlation. Breast J. 9 (3): 252-3. Breast J (link) - Pubmed citation
- 7. Eurorad teaching files : Case 9277
- 8. Eurorad teaching files : Case 3138
- 9. Plichta, Jennifer K., Hughes, Kevin. Radiation-Induced Angiosarcoma after Breast-Cancer Treatment. (2017) The New England journal of medicine. 376 (4): 367. doi:10.1056/NEJMicm1516482 - Pubmed
- 10. Kunkiel M, Maczkiewicz M, Jagiełło-Gruszfeld A, Nowecki Z. Primary angiosarcoma of the breast-series of 11 consecutive cases-a single-centre experience. (2018) Current oncology (Toronto, Ont.). 25 (1): e50-e53. doi:10.3747/co.25.3816 - Pubmed
- 11. Nascimento AF, Raut CP, Fletcher CD. Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic. (2008) The American journal of surgical pathology. 32 (12): 1896-904. doi:10.1097/PAS.0b013e318176dbc7 - Pubmed
- 12. Chen KT, Kirkegaard DD, Bocian JJ. Angiosarcoma of the breast. (1980) Cancer. 46 (2): 368-71. Pubmed